Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to ...

As pharma companies big and small play up their U.S. investment plans during the second Trump administration, the particulars ...

Insiders have been trading these 5 stocks: (($MSFT)), (($AMD)), (($BA)), (($ABBV)) and (($LLY)). Here is a breakdown of their recent trades and ...

Analysts are intrested in these 5 stocks: ( ($ABBV) ), ( ($DOW) ), ( ($KTOS) ), ( ($RKT) ) and ( ($AMAT) ). Here is a breakdown of their recent ...

AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...

The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.

Over the past five years, ABBV has experienced a negative one-day return following its earnings announcements in 65% of ...

AbbVie Inc.'s Q2 2025 results showcase Skyrizi & Rinvoq's growth, strong finances, and a promising pipeline. Click for my ...

As for its neuroscience portfolio, AbbVie has added $300 million, putting its projection for the year at $10.5 billion, which ...

AbbVie will invest $195M to expand API manufacturing at its North Chicago plant, boosting U.S. pharmaceutical innovation, ...

The promising results, along with a separate FDA decision, could signal a major expansion of the use of the two companies' ...

The project aims to enhance AbbVie’s chemical synthesis capacity to support next-generation neuroscience, immunology, and ...